title: Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
authors.forename: S
authors.initials: S
authors.lastname: Morimoto
authors.forename: E
authors.initials: E
authors.lastname: Kido
authors.forename: M
authors.initials: M
authors.lastname: Higashi
authors.forename: N
authors.initials: N
authors.lastname: Sumitani
authors.forename: H
authors.initials: H
authors.lastname: Takagishi
authors.forename: S
authors.initials: S
authors.lastname: Kakimoto
authors.forename: K
authors.initials: K
authors.lastname: Someya
authors.forename: T
authors.initials: T
authors.lastname: Morita
authors.forename: T
authors.initials: T
authors.lastname: Iwasaka
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: A
authors.initials: A
authors.lastname: Yasui
mesh_terms: D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D015377:Cilastatin / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D016983:Enterococcus / Q000302:isolation & purification; D005260:Female; D005773:Gastroscopy / Q000009:adverse effects*; D058869:Gynecological Examination / Q000009:adverse effects*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D055502:Secondary Prevention; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D014640:Vancomycin; D015378:Imipenem; D000583:Amikacin; D000077728:Cilastatin, Imipenem Drug Combination